Cited by 326Smoking Behavior and CessationGlobal Cancer Incidence and ScreeningChronic Obstructive Pulmonary Disease (COPD) Research

Trends in smoking prevalence and implication for chronic diseases in China: Serial national cross-sectional surveys from 2003 to 2013

Wang, Minghuan, Luo, Xiang, Xu, Shabei, Liu, Wenhua, Ding, Fengfei, Zhang, Xiaoxiang, Wang, Liang, Liu, Jian +2 more·2019·The Lancet Respiratory Medicine

Abstract

Background China is the world's largest consumer of tobacco and has a large smoking-related chronic disease burden. In this nationwide study, we aimed to evaluate smoking prevalence and its implication on chronic diseases in the Chinese population.Methods We collected data from serial cross-sectional National Health Service Surveys done in China in 2003, 2008, and 2013. These surveys cover all 31 provinces, autonomous regions, and municipalities in mainland China, and use multistage stratified cluster sampling. We divided mainland China into east, central, and west regions and then sampled counties from each region stratified by urban and rural areas. All respondents aged 15 years or older in the selected households were eligible. We analysed the variation in smoking prevalence from 2003 to 2013, further identified risk factors for smoking, and assessed the association between smoking and chronic diseases by using multiple logistic regression.Findings The number of individuals interviewed and involved in the study was 153 450 in 2003, 145 223 in 2008, and 229 676 in 2013. The standardised smoking prevalence in China was consistently high, with a proportion of current smokers of 26·0% (95% CI 25·8-26·2) in 2003, 24·9% (24·8-25·1) in 2008, and 25·2% (25·1-25·4) in 2013 (p value for trend 0·5062). For men, prevalence was 48·4% (48·1-48·7) in 2003, 47·0% (46·6-47·4) in 2008, and 47·2% (46·9-47·5) in 2013. For women, prevalence was 3·1% (3·0-3·2) in 2003, 2·3% (2·2-2·5) in 2008, and 2·7% (2·6-2·8) in 2013. Smoking prevalence varied in different regions, and we identified four major patterns. While a consistently high proportion of Chinese men smoked, the standardised smoking prevalence in women younger than 40 years increased from 1·0% in 2003 to 1·6% in 2013. Moreover, the smoking prevalence among adolescent smokers aged 15-24 years increased from 8·3% in 2003 to 12·5% in 2013. Alcohol consumption was closely linked to smoking in adolescents (odds ratio 7·5, 95% CI 6·9-8·1). Risk factors for adolescent smoking were having older family members who smoke (1·9, 1·8-1·9) and low level education (1·3, 1·2-1·4). Increased risks of chronic diseases were related to smoking (1·1, 1·0-1·1), with higher risks related to early smoking initiation (1·1, 1·0-1·1) and long-term smoking (1·2, 1·2-1·3).Interpretation The implementation of tobacco control policies in China since the signing of the WHO Framework Convention on Tobacco Control in 2003 has not been effective in reducing smoking prevalence. Smoking prevalence among adolescents of both genders has increased substantially and there has been a steady increase among young women. More practical and effective policies targeting adolescents and women are urgently needed. Action is needed to prevent the large and growing smoking-related chronic disease burden further increasing as China's population ages.Funding National Health Commission of the People's Republic of China.

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(18)30432-6

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, M., Luo, X., Xu, S., Liu, W., Ding, F., Zhang, X., Wang, L., Liu, J., Hu, J., & Wang, W.
Affiliations
  • Tongji Hospital (CN)
  • National Health and Family Planning Commission (CN)
Corresponding author
Wang, Wei
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2019-01
Volume
7
Issue
1
Pages
35-45
ISSN
2213-2600 (ISSN-L)
OpenAlex
W2898484931
Cited by
326
References
24
Citations by year
2026: 16 · 2025: 42 · 2024: 41 · 2023: 47 · 2022: 71 · 2021: 44 · 2020: 47 · 2019: 14 · 2018: 2
FWCI
18.34
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet Respiratory Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Huazhong University of Science and Technology
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
tobacco use trends, chronic disease, smoking risk factors, urban-rural differences, sex differences in smoking, China, tobacco control, smoking cessation, lung cancer, cardiovascular disease, stroke, chronic obstructive pulmonary disease, diabetes mellitus, cancer mortality
MeSH terms
Cigarette Smoking, Adolescent, Adult, China, Chronic Disease, Cross-Sectional Studies, Female, Health Surveys, Humans, Male, Middle Aged, Risk Factors, Prevalence, Logistic Models, Cost of Illness, Age Distribution, Sex Distribution, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review